Search Orphan Drug Designations and Approvals
-
Generic Name: | Sodium phenylbutyrate |
---|---|
Date Designated: | 04/24/1998 |
Orphan Designation: | For use as an adjuct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Elan Drug Delivery, Inc. 1300 Gould Dr. Gainesville, Georgia 30504 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-